Evidence map›Paper›PMID 30516578›Full record

ReviewCurrent opinion in organ transplantation2019

Why some organ allografts are tolerated better than others: new insights for an old question.

Travis D Hull, Gilles Benichou, Joren C Madsen

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in organ transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Skin Cancer in Solid Organ Transplant Recipients: A Review.American journal of clinical dermatology · 2026
    Review
  4. Article
  5. Organ-Specific Determinants of Tolerance and the Unique Challenge of Vascularized Composite Allotransplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  6. What makes the kidney so tolerant?The Journal of clinical investigation · 2024
    Article
  7. The Transplant Bellwether: Endothelial Cells in Antibody-Mediated Rejection.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Progress towards xenogenic tolerance.Current opinion in organ transplantation · 2020
    Review
  12. Article
  13. Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Travis D HullDepartment of Surgery, Massachusetts General Hospital.
Gilles BenichouCenter for Transplantation Science.
Joren C MadsenDepartment of Surgery, Massachusetts General Hospital.
Harvard University · USMassachusetts General Hospital · US

Funding

XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
Project 3: The Role of Erythropoietin in Kidney Transplant ToleranceP01AI123086 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2016 to 2020
$10.6M
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantationU01AI131470 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2017 to 2022
$5.6M
Exosomes and Donor Antigen Cross-dressing in Pancreatic Islet TransplantationR01DK115618 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2018 to 2021
$1.8M
Effects of Lymphangiogenesis Blockade on Skin Allograft RejectionR21AI100278 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2012 to 2013
$370k
NHLBI NIH HHS P01 HL018646NIAID NIH HHS P01 AI123086NIAID NIH HHS R21 AI100278NIAID NIH HHS U01 AI131470NIDDK NIH HHS R01 DK115618
6 · The paper itself

Abstract

purpose of reviewThere is great variability in how different organ allografts respond to the same tolerance induction protocol. Well known examples of this phenomenon include the protolerogenic nature of kidney and liver allografts as opposed to the tolerance-resistance of heart and lung allografts. This suggests there are organ-specific factors which differentially drive the immune response following transplantation. RECENT

findingsThe specific cells or cell products that make one organ allograft more likely to be accepted off immunosuppression than another are largely unknown. However, new insights have been made in this area recently. SUMMARY: The current review will focus on the organ-intrinsic factors that contribute to the organ-specific differences observed in tolerance induction with a view to developing therapeutic strategies to better prevent organ rejection and promote tolerance induction of all organs.

Indexed as

AllograftsGraft RejectionHumansTransplantation, Homologous

Identifiers

PMID30516578
PMCPMC6467256
OpenAlexW2904650423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.